Literature DB >> 3033314

Cellular mutation mediates T-antigen-positive revertant cells resistant to simian virus 40 transformation but not to retransformation by polyomavirus and adenovirus type 2.

M Bauer, E Guhl, M Graessmann, A Graessmann.   

Abstract

T-antigen-positive transformation revertant cell lines were isolated from fully simian virus 40 (SV40)-transformed Fisher rat embryo fibroblast cells (REF 52 cells) by methionine starvation. Reversion of the transformed cells (SV-52 cells) was caused by a mutation within the cellular genome. To demonstrate this, we isolated SV40 DNA from the host genome, inserted it into plasmid pSPT18 DNA, cloned it in Escherichia coli, and microinjected it into the nuclei of the REF 52 cells. Fully transformed cells were obtained with the same efficiency (20 to 25%) as after microinjection of wild-type SV40 DNA I. Furthermore, the revertant cells were resistant to retransformation by SV40. Following microinjection of wild-type SV40 DNA I, 42 independent cell lines were isolated. Cells of all analyzed lines acquired additional SV40 DNA copies, but changes in the cell morphology or growth characteristic were not demonstrable. However, the revertants were retransformable with a high efficiency after polyomavirus and adenovirus type 2 infections or microinjection. Also, fusion of the revertant cells with the grandparental REF 52 cells led to restoration of the transformed state.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033314      PMCID: PMC254185          DOI: 10.1128/JVI.61.6.1821-1827.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Fused cells are suited for microinjection.

Authors:  A Graessmann; M Graessmann; C Mueller
Journal:  Biochem Biophys Res Commun       Date:  1979-05-28       Impact factor: 3.575

2.  Function of simian virus 40 gene A in transforming infection.

Authors:  P Tegtmeyer
Journal:  J Virol       Date:  1975-03       Impact factor: 5.103

3.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

4.  Simian virus 40 functions required for the establishment and maintenance of malignant transformation.

Authors:  R G Martin; J Y Chou
Journal:  J Virol       Date:  1975-03       Impact factor: 5.103

5.  Simian virus 40 gene A function and maintenance of transformation.

Authors:  M Osborn; K Weber
Journal:  J Virol       Date:  1975-03       Impact factor: 5.103

6.  Mapping of early SV40-specific functions by microinjection of different early viral DNA fragments.

Authors:  C Mueller; A Graessmann; M Graessmann
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

7.  Isolation and characterization of revertant cell lines. 3. Isolation of density-revertants of SV40-transformed 3T3 cells using colchicine.

Authors:  A Vogel; R Risser; R Pollack
Journal:  J Cell Physiol       Date:  1973-10       Impact factor: 6.384

Review 8.  Germ-line transformation of mice.

Authors:  R D Palmiter; R L Brinster
Journal:  Annu Rev Genet       Date:  1986       Impact factor: 16.830

9.  Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.

Authors:  D I Linzer; A J Levine
Journal:  Cell       Date:  1979-05       Impact factor: 41.582

10.  Retransformation of a simian virus 40 revertant cell line, which is resistant to viral and DNA infections, by microinjection of viral DNA.

Authors:  A Graessmann; M Graessmann; W C Topp; M Botchan
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

View more
  9 in total

1.  MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection.

Authors:  W Henning; G Rohaly; T Kolzau; U Knippschild; H Maacke; W Deppert
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Phenotype-specific phosphorylation of simian virus 40 tsA mutant large T antigens in tsA N-type and A-type transformants.

Authors:  U Knippschild; J Kiefer; T Patschinsky; W Deppert
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Isolation of recessive (mediator-) revertants from NIH 3T3 cells transformed with a c-H-ras oncogene.

Authors:  H Yamada; T Omata-Yamada; N Wakabayashi-Ito; S G Carter; P Lengyel
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

4.  Homologous recombination of SV40 DNA in COS7 cells occurs with high frequency in a gene dose independent fashion.

Authors:  W Rommerskirch; I Graeber; M Grässmann; A Grässmann
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

5.  Simian virus 40 large T antigen induces or activates a protein kinase which phosphorylates the transformation-associated protein p53.

Authors:  K H Scheidtmann; A Haber
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

6.  Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen.

Authors:  K H Scheidtmann; M C Mumby; K Rundell; G Walter
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

7.  The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300.

Authors:  M L Avantaggiati; M Carbone; A Graessmann; Y Nakatani; B Howard; A S Levine
Journal:  EMBO J       Date:  1996-05-01       Impact factor: 11.598

8.  Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo.

Authors:  Heidrun Hirner; Cagatay Günes; Joachim Bischof; Sonja Wolff; Arnhild Grothey; Marion Kühl; Franz Oswald; Florian Wegwitz; Michael R Bösl; Anna Trauzold; Doris Henne-Bruns; Christian Peifer; Frank Leithäuser; Wolfgang Deppert; Uwe Knippschild
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

9.  Independent expression of the transforming amino-terminal domain of SV40 large I antigen from an alternatively spliced third SV40 early mRNA.

Authors:  J Zerrahn; U Knippschild; T Winkler; W Deppert
Journal:  EMBO J       Date:  1993-12       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.